D'ELIOS, MARIO MILCO
 Distribuzione geografica
Continente #
NA - Nord America 15.927
EU - Europa 13.822
AS - Asia 6.896
SA - Sud America 902
AF - Africa 208
OC - Oceania 145
Continente sconosciuto - Info sul continente non disponibili 3
Totale 37.903
Nazione #
US - Stati Uniti d'America 15.763
PL - Polonia 4.623
RU - Federazione Russa 3.418
IT - Italia 2.259
SG - Singapore 1.783
CN - Cina 1.565
HK - Hong Kong 1.401
IE - Irlanda 914
VN - Vietnam 754
SE - Svezia 732
BR - Brasile 730
KR - Corea 624
DE - Germania 396
FI - Finlandia 382
UA - Ucraina 357
FR - Francia 338
IN - India 208
GB - Regno Unito 198
AU - Australia 143
BD - Bangladesh 105
ID - Indonesia 90
CA - Canada 79
TR - Turchia 76
CI - Costa d'Avorio 63
JP - Giappone 63
AR - Argentina 55
JO - Giordania 54
CH - Svizzera 50
MX - Messico 46
NL - Olanda 45
IQ - Iraq 44
ZA - Sudafrica 38
EC - Ecuador 34
ES - Italia 26
AT - Austria 20
VE - Venezuela 20
NG - Nigeria 18
BE - Belgio 16
PK - Pakistan 16
MA - Marocco 15
CO - Colombia 14
SC - Seychelles 14
DZ - Algeria 12
PE - Perù 12
CL - Cile 11
KE - Kenya 11
BJ - Benin 10
JM - Giamaica 10
PY - Paraguay 10
UZ - Uzbekistan 10
BO - Bolivia 9
EG - Egitto 9
SA - Arabia Saudita 9
TN - Tunisia 9
KG - Kirghizistan 8
LT - Lituania 8
NP - Nepal 8
AE - Emirati Arabi Uniti 7
AZ - Azerbaigian 7
MY - Malesia 7
PH - Filippine 7
UY - Uruguay 7
CZ - Repubblica Ceca 6
DO - Repubblica Dominicana 6
IR - Iran 6
KZ - Kazakistan 6
CR - Costa Rica 5
DK - Danimarca 5
LB - Libano 5
PS - Palestinian Territory 5
BH - Bahrain 4
IL - Israele 4
TH - Thailandia 4
BY - Bielorussia 3
GE - Georgia 3
HN - Honduras 3
HR - Croazia 3
LV - Lettonia 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
BG - Bulgaria 2
BN - Brunei Darussalam 2
ET - Etiopia 2
EU - Europa 2
GT - Guatemala 2
MD - Moldavia 2
MM - Myanmar 2
NI - Nicaragua 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
OM - Oman 2
PA - Panama 2
PT - Portogallo 2
RS - Serbia 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
Totale 37.884
Città #
Warsaw 4.620
Santa Clara 3.046
Ashburn 1.743
Fairfield 1.416
Singapore 1.243
Hong Kong 995
Dublin 906
Chandler 833
Woodbridge 643
Seoul 619
Cambridge 612
Seattle 585
Jacksonville 540
Houston 521
Wilmington 475
Milan 424
San Jose 423
Beijing 373
Hefei 307
Ann Arbor 264
Princeton 237
Altamura 226
Los Angeles 219
Lawrence 211
Buffalo 210
Ho Chi Minh City 202
Lauterbourg 192
Florence 181
Rome 181
Council Bluffs 176
Hanoi 173
Boardman 161
Medford 156
The Dalles 149
Boston 137
Dallas 136
Mumbai 134
Helsinki 130
Melbourne 127
Moscow 123
New York 113
Munich 100
San Diego 82
Paris 80
São Paulo 77
Dong Ket 76
Shanghai 70
Jakarta 69
Abidjan 63
Kent 56
Tokyo 56
Turku 50
Turin 49
Phoenix 44
Naples 40
Redondo Beach 40
Izmir 37
Norwalk 37
Orem 37
Bern 36
Frankfurt am Main 36
London 36
Verona 36
Bologna 35
Haiphong 34
Clifton 30
Figino 30
Guangzhou 30
Falls Church 29
Toronto 29
Da Nang 27
Chicago 26
Denver 26
Hillsboro 26
Palermo 26
Rio de Janeiro 26
San Francisco 25
Miano 23
West Jordan 21
Yubileyny 21
Salerno 20
Auburn Hills 19
Belo Horizonte 19
Montreal 19
Baghdad 18
Brooklyn 18
Genoa 18
Johannesburg 18
Abuja 17
Andover 17
Bengaluru 17
Tianjin 17
Venice 17
Bari 16
Chennai 16
Dearborn 16
Guayaquil 16
Atlanta 14
Brescia 14
Brussels 14
Totale 26.173
Nome #
Behçet's syndrome patients exhibit specific microbiome signature. 509
H(+),K(+)-ATPase (proton pump) is the target autoantigen of Th1-type cytotoxic T cells in autoimmune gastritis. Gastroenterology 410
H+K+-A Tpase (proton pump) is the target autoantigen of Thl-type cytotoxic T cells in autoimmune gastritis 399
H(+),K(+)-atpase (proton pump) is the target autoantigen of Th1-type cytotoxic T cells in autoimmune gastritis. 383
An approach to differential diagnosis of antiphospholipid antibody syndrome and related conditions. 357
Characterization of tumor antigen peptide-specific T cells isolated from the neoplastic tissue of patients with gastric adenocarcinoma. 354
Human 60 kDa heat shock protein is a target autoantigen of T cells derived from atherosclerotic plaques. 350
Chlamydophila pneumoniae phospholipase D (CpPLD) drives Th17 inflammation in human atherosclerosis. 340
The Helicobacter cinaedi antigen CAIP participates in atherosclerotic inflammation by promoting the differentiation of macrophages in foam cells 336
Long-term efficacy and safety of anakinra in a patient with Behçet's disease and concomitant tuberculosis infection 335
Arterial occlusion mimicking vasculitis in a patient with incontinentia pigmenti 331
Borrelia burgdorferi NapA-driven Th17 cell inflammation in lyme arthritis. 330
Treponema pallidum (syphilis) antigen TpF1 induces angiogenesis through the activation of the IL-8 pathway 330
Expression of the p66Shc protein adaptor is regulated by the activator of transcription STAT4 in normal and chronic lymphocytic leukemia B cells 316
Pathogenesis and potential therapeutic targets in systemic lupus erythematosus: from bench to bedside 313
Myelin-specific T cells carry and release magnetite PGLA-PEG COOH nanoparticles in the mouse central nervous system 309
Tumor-associated macrophages as major source of APRIL in gastric MALT lymphoma. 302
A T cell suppressive circuitry mediated by CD39 and regulated by ShcC/RAI is induced in astrocytes by encephalitogenic T cells 301
Impaired T-cell regulation of B-cell growth in Helicobacter pylori--related gastric low-grade MALT lymphoma. 299
The Neutrophil Activating Protein of Helicobacter pylori promotes T helper type 1 immune responses. 297
Reply to letter by Nardelli and Schell commenting on the pathogenesis of Lyme arthritis 296
CD25 deficiency: A new conformational mutation prevents the receptor expression on cell surface 296
Molecular mimicry between Helicobacter pylori antigens and H/K-ATPase in human gastric autoimmunity. 290
Marcatori e funzioni dei linfociti th1 e th2. 289
Predominant Th1 cell infiltration in acute rejection episodes of human kidney grafts 288
Intra-tumoral IFN-gamma-producing Th22 cells correlate with TNM staging and the worst outcomes in pancreatic cancer 286
A Robust Design for Cellular Vehicles of Gold Nanorods for Multimodal Imaging 275
The adenylate cyclase toxins of Bacillus anthracis and Bordetella pertussis promote Th2 cell development by shaping T cell antigen receptor signaling. 274
T cells in gastric cancer: friends or foes. 273
Cytokine BAFF released by Helicobacter pylori-infected macrophages triggers the Th17 response in human chronic gastritis. 273
p66Shc deficiency enhances CXCR4 and CCR7 recycling in CLL B cells by facilitating their dephosphorylation-dependent release from β-arrestin at early endosomes 272
USE OF THE NEUTROPHIL ACTIVATING PROTEIN OF HELICOBACTER PYLORI (HP-NAP) AND/OR OF ITS PORTIONS AS ADJUVANTS FOR THE DEVELOPMENT OF T HELPER TYPE 1 (TH1) IMMUNE RESPONSES 269
Structure and immunomodulatory property relationship in NapA of Borrelia burgdorferi. 267
Th1 effector cells specific for Helicobacter pylori in the gastric antrum of patients with peptic ulcer disease 257
T helper type-1 lymphocyte-drive inflammation in human atherosclerotic lesions. 254
LMW-PTP targeting potentiates the effects of drugs used in chronic lymphocytic leukemia therapy 252
Digital ulcers secondary to Sneddon's syndrome successfully treated with Bosentan: not only useful in Systemic Sclerosis 252
Potential Role of M. tuberculosis Specific IFN-γ and IL-2 ELISPOT Assays in Discriminating Children with Active or Latent Tuberculosis 249
T cell clones in human trichinellosis: evidence for a mixed Th1/Th2 response 246
Novel M. tuberculosis specific IL-2 ELISpot assay discriminates adult patients with active or latent tuberculosis 244
The immune modulating activity of the Helicobacter pylori HP-NAP: friend or foe? 242
Bioethics under the Tuscan sun 240
Cytotoxic T Cells in H. pylori -Related Gastric Autoimmunity andGastric Lymphoma 228
T cells and adoptive immunotherapy: recent developments and future prospects in gastrointestinal oncology. 224
The lipoprotein HP1454 of Helicobacter pylori regulates T-cell response by shaping T-cell receptor signalling 223
Thrombosis in vasculitis: from pathogenesis to treatment 211
Intrinsic factor recognition promotes T helper 17/T helper 1 autoimmune gastric inflammation in patients with pernicious anemia. 210
Cytotoxic Th1 and Th17 cells infiltrate the intestinal mucosa of Behcet patients and exhibit high levels of TNF-α in early phases of the disease 200
Role of Mycobacterium avium lysate INF-γ, IL-17, and IL-2 ELISPOT assays in diagnosing nontuberculous mycobacteria lymphadenitis in children 200
Prevalence of allergy and asthma in a rural community of children and adults in Bolivian Chaco 199
Inflammatory marker changes in a 24-month dietary and physical activity randomised intervention trial in postmenopausal women 196
Characterization of H/K-ATPase T-cell epitopes in human autoimmune gastritis. 194
The glycopeptide csf114(glc) detects serum antibodies in multiple sclerosis. 193
In vivo CD30 expression in human diseases with predominant activation of Th2-like T cells. 191
Systemic lupus erythematosus: immunopathogenesis and novel therapeutic targets 189
An update on human Th1 and Th2 cells 189
Interleukin-17/Interleukin-21 and Interferon-g producing T cells specific for β2 Glycoprotein I in atherosclerosis inflammation of systemic lupus erythematosus patients with antiphospholipid syndrome 187
The immune receptor CD300e negatively regulates T cell activation by impairing the STAT1-dependent antigen presentation 186
Orchestration of inflammation and adaptive immunity in Borrelia burgdorferi-induced arthritis by neutrophil-activating protein A 185
LIOFeron®TB/LTBI: A novel and reliable test for LTBI and tuberculosis 185
Active tuberculosis in Africa is associated with reduced Th1 and increased Th2 activity in vivo. 183
Vav1 haploinsufficiency in a common variable immunodeficiency patient with defective T-cell function. 183
Autoantibodies against β1-Adrenergic Receptors: Response to Cardiac Resynchronization Therapy and Renal Function 182
Role of Th1/Th2 cytokines in HIV infection. 181
Peripheral ENO1-specific T cells mirror the intratumoral immune response and their presence is a potential prognostic factor for pancreatic adenocarcinoma 181
The adaptor protein Rai/ShcC promotes astrocyte-dependent inflammation during Experimental Autoimmune Encephalomyelitis. 180
β2 Glycoprotein I Recognition Drives Th1 Inflammation in Atherosclerotic Plaques of Patients with Primary Antiphospholipid Syndrome 179
A CVID-associated variant in the ciliogenesis protein CCDC28B disrupts immune synapse assembly 178
Cardiovascular oncology: a new discipline inside internal medicine? 177
Targeting of tumor cells by custom antigen transfer: a novel approach for immunotherapy of cancer 176
Moraxella catarrhalis-specific Th1 cells in BAL fluids of chronic obstructive pulmonary disease patients. 172
Defining the Helicobacter pylori Disease-Specific Antigenic Repertoire 172
The Shc family protein adaptor, Rai, acts as a negative regulator of Th17 and Th1 cell development. 172
CSF/serum matrix metallopeptidase‐9 ratio discriminates neuro Behçet from multiple sclerosis 172
Elevated IL-19 Serum Levels in Patients With Pernicious Anemia and Autoimmune Gastritis 171
Behçet's syndrome pathophysiology and potential therapeutic targets 170
Differential Diagnosis 169
In vivo relevance of CD30 in atopic dermatitis. 169
Pathogenesis and potential therapeutic targets in systemic lupus erythematosus: from bench to bedside 169
Prevention of miscarriage in antiphospholipid syndrome 169
IFN-g-inducible protein (IP-10/CXCL)10 and pentraxin (PTX)3 plasma levels are tools for monitoring inflammation and disease activity in M. tuberculosis infection. 168
Case Report: Signal Transducer and Activator of Transcription 3 Gain-of-Function and Spectrin Deficiency: A Life-Threatening Case of Severe Hemolytic Anemia 167
Skin IL-17A and IFN-γ Production Correlate with Disease Severity in Patients with Psoriasis and Streptococcal Infection 165
Targeting IL-23 in human diseases. 165
[Therapy for non-muscle invasive bladder cancer: HP-NAP]. 165
Allergen exposure induces the activation of allergen-specific Th2 cells in the airway mucosa of patients with allergic respiratory disorders. 163
Pulmonary hemorrhage: not only vasculitis. 162
Helicobacter pylori, T cells and cytokines: the "dangerous liaisons". 161
Immunosuppression of TH2 responses in Trichinella spiralis infection by Helicobacter pylori Neutrophil Activating Protein 157
Decrease of serological markers of Th2 activity in a context of decreasing intestinal helminth prevalence: Chaco Region, Plurinational State of Bolivia 157
Stimulation of TH1 response by Helicobacter pylori neutrophil activating protein decreases the protective role of IgE and eosinophils in experimental trichinellosis. 153
Increased IL-17A Serum Levels and Gastric Th17 Cells in Helicobacter pylori-Infected Patients with Gastric Premalignant Lesions 152
Impaired TH2 response in patients with Vav1-deficient common variable immunodeficiency with T-cell defects. 151
Usefulness of 13C-Urea Breath Test in the diagnosis of gastric Helicobacter pylori infection. 151
Suppression of T-lymphocyte activation and chemotaxis by the adenylate cyclase toxin of Bordetella pertussis. 151
Preferential expression of CD30 by human CD4+ T-cells producing Th2-type cytokines. 150
Novel immunotherapeutic strategies of gastric cancer treatment 150
Allergen exposure induces the activation of allergen-specific th2 cells in the airway mucosa of patients with allergic respiratory disorders. 150
Inflammation and host response. 149
Soluble CD30 and lymphocyte activation gene-3 (CD223), as potential serological markers of T helper-type cytokine response induced by acellular pertussis vaccine. 149
Totale 23.016
Categoria #
all - tutte 97.660
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 97.660


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.452 43 153 108 68 58 48 48 96 63 60 255 452
2022/20233.741 376 630 163 271 298 644 433 399 319 21 120 67
2023/20241.233 47 150 251 66 71 251 39 161 18 89 50 40
2024/20259.302 332 1.003 621 1.381 2.623 1.134 115 630 482 299 342 340
2025/202610.599 1.144 1.485 822 782 968 405 1.152 572 685 687 311 1.586
2026/202736 36 0 0 0 0 0 0 0 0 0 0 0
Totale 38.188